23 May 2013
Keywords: lilly, repligen, expand, biotech, deal, eli, agreed
Article | 12 June 1995
Repligen and Eli Lilly have agreed to renew their biotechnology and
genetic engineering licensing agreement and extend it through 1996. The
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 1995
22 May 2013
© 2013 thepharmaletter.com